Insider Trading February 24, 2026

Tredegar Ten-Percent Owner Disposes of 5,484 Shares in Late-February Trades

William M. Gottwald reduced holdings by roughly $48,278 in two transactions; retains substantial positions across multiple trusts

By Caleb Monroe TG
Tredegar Ten-Percent Owner Disposes of 5,484 Shares in Late-February Trades
TG

William M. Gottwald, identified as a ten percent owner of Tredegar Corp (NYSE: TG), sold a combined 5,484 shares on February 20 and February 23, 2026, for roughly $48,278. The transactions, recorded in an SEC filing, occurred at prices between $8.803 and $8.806. After the sales, Gottwald continues to hold large direct and indirect positions across several trusts and family accounts. The sale prices were close to the stock's recent market price and sit below the 52-week high; available analysis notes the shares appear slightly overvalued versus a Fair Value estimate.

Key Points

  • William M. Gottwald, a ten percent owner of Tredegar Corp (NYSE: TG), sold 5,484 shares on February 20 and February 23, 2026, for about $48,278.
  • Sale prices ranged from $8.803 to $8.806 and were close to the recent market price of $8.82; this level is approximately 6% below the 52-week high of $9.43 and the stock is up 22% year-to-date.
  • After the transactions, Gottwald continues to hold substantial positions across multiple trusts and family accounts, with direct and indirect holdings totaling several hundred thousand shares.

An SEC filing shows that William M. Gottwald, listed as a ten percent owner of TREDEGAR CORP (NYSE: TG), sold a total of 5,484 shares of the company's common stock in two separate trades on February 20 and February 23, 2026.

The sales generated approximately $48,278 in proceeds. Traded prices ranged narrowly from $8.803 to $8.806 per share. The filing breaks the sales down by date: 1,023 shares were sold on February 20 and 4,461 shares were sold on February 23.

The prices at which the shares moved align closely with the prevailing market quote of $8.82. That market level is about 6% below the stock's 52-week high of $9.43. Over the year to date, the share price has appreciated by 22%. Available analysis indicates the shares are slightly overvalued relative to a stated Fair Value estimate.


Holdings after the transactions

The filing details Gottwald's continued holdings across several accounts and trusts. Following the disposals, his direct holding stands at 578,483 shares, held as co-trustee of the Residual 10-Year CLAT UA FDGJR Living Trust. He is also recorded as indirectly holding 6,197 shares owned by his wife. Additional positions tied to him include 847,470 shares held as co-trustee FBO the reporting person’s family u/w Floyd D. Gottwald, and 211,260 shares held as trustee of the William Michael Gottwald Revocable Trust.


Context and market signals

The narrow range of trade prices and the timing across two days produced modest proceeds relative to Gottwald's larger, continuing ownership positions. The filing provides no explanatory commentary on the rationale for the sales; it supplies the transactional facts and the post-transaction ownership totals.

From a market-data perspective, the transactions occurred at prices essentially in line with the market quote and below the year's peak price, while year-to-date performance shows a positive return of 22%. Concurrent valuation commentary notes a slight overvaluation versus an internal Fair Value estimate.


What the filing does and does not show

  • The filing records the exact share counts, trade dates, and price range for the sold shares.
  • It enumerates Gottwald's direct and indirect holdings after the sales across several trusts and family accounts.
  • The filing does not explain motivation, planned future trades, or any intended change in long-term ownership strategy.

Risks

  • The filing does not state the motive for the sales, leaving uncertainty about whether the transactions reflect personal liquidity needs, portfolio rebalancing, or other reasons - this uncertainty affects investor interpretation in the equity markets.
  • Available valuation analysis indicates the shares may be slightly overvalued relative to a Fair Value estimate, introducing downside risk if market reassessment occurs - this impacts shareholders and market sentiment.
  • The share price remained below its 52-week high at the time of the transactions, which may reflect volatility or resistance levels in the stock - this is a market-level uncertainty for traders and investors.

More from Insider Trading

Progressive Accounting Chief Disposes $55K in Stock as Shares Trade Near Yearly Low Mar 23, 2026 Old Second Bancorp Vice Chairman Disposes $429K in Shares; Ownership Stakes and Recent Results Also Detailed Mar 23, 2026 Vicor Chairman Disposes $7.9 Million in Stock; Transaction Executed Under 10b5-1 Plan Mar 23, 2026 Nutex Health President Buys $23,706 in Stock as Q4 Revenue Slumps 41.1% Mar 23, 2026 Nutex Health Director Buys $14,033 in Stock as Q4 Revenue Slumps 41.1% Mar 23, 2026